Global Longevity Market
$320B to $610B
2025 to 2030, CAGR 13.7%.
Partner Assets
Selected business-case metrics and partnership-ready materials for scientific and strategic collaborators.
Senolytics Segment
$2.1B to $8.7B
2025 to 2032, CAGR 22.4%.
R&D Time Advantage
4 to 6 years
Versus 8 to 12 years in traditional pipelines.
Cost Efficiency Target
40 to 60% lower
Faster hit finding and earlier risk filtering via AI/ML.
Available asset package
One-pager, business case summary, platform workflow overview, and current research track snapshot.